Friday, Jan 31, 2025 · SEC filings
What the smart money revealed on Jan 31
556 insider filings came in. We hid 39 planned (10b5-1) sellers and 427 people whose filings were routine, like grants and tax withholding.
Calamos Strategic Total Return Fund (CSQ) VP and CFO Thomas Herman bought $425K
23,190 shares on the open market. Not a grant or an option exercise.
Comstock Resources (CRK) Director Elizabeth Davis bought $200K
10,725 shares on the open market. Not a grant or an option exercise.
Oak Valley Bancorp (OVLY) Director H. Randolph Holder Jr. bought $156K
6,000 shares on the open market. Not a grant or an option exercise. Their past buys: 4 of 4 checked quarters beat the typical stock 6 months later.
MSC Income Fund (MSIF) Managing Director Nicholas Meserve bought $155K
10,000 shares on the open market. Not a grant or an option exercise.
Abbott Laboratories (ABT) Executive Vice President Hubert Allen sold $24.3M
Not marked as a planned 10b5-1 sale. Most of the shares sold came from stock options they exercised the same day. Still holds 184,806 shares directly.
Tempus AI (TEM) CEO and Chairman Eric Lefkofsky sold $13.3M
Not marked as a planned 10b5-1 sale. Sold 4% of the shares they held directly. Still holds 5.53M shares.
Ryan Specialty (RYAN) Director Nicholas Cortezi sold $2.63M
Not marked as a planned 10b5-1 sale. Sold every share held directly.
Show 20 more real buys
Show 48 more real sales
13F season
Holdings as of Dec 31, 2024 are due Feb 14
81 funds have filed so far. 58 filed for the quarter before.
Biggest real insider buys, Jan 25–31
Open-market buys by officers and directors, filed in the 7 days up to Jan 31.
Free weekly email
Each week's biggest real insider buys, cluster buys and fund moves, every one dated. One email a week. Unsubscribe in one click.